Retrospective study demonstrates improved diagnostic accuracy of O-RADS MRI in adnexal lesions by incorporating ADC values, indicating enhanced malignancy prediction.
Background Ovarian cancer is the second most common gynecologic malignancy, and accurate characterization of adnexal lesions is essential for management. While ovarian-adnexal reporting and data system magnetic resonance imaging (O-RADS MRI) improves diagnostic performance, indeterminate cases remain challenging. Diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) values offer additional functional criteria that may refine O-RADS stratification. This study aimed to assess the added value of ADC measurements in improving the diagnostic accuracy of O-RADS MRI for adnexal lesions. Results This retrospective study included 66 female patients (18 to 67 years, with a mean of 43.9 ± 13.8 years) with 78 MRI-detected ovarian or adnexal lesions categorized as O-RADS 3, 4, or 5. For MRI-based O-RADS scoring, sensitivity, specificity, positive predictive value, negative predictive value, and overall diagnostic accuracy were 88.4%, 88.6%, 90.5%, 86.1%, and 88.5%, respectively. For qualitative diffusion-weighted imaging analysis, the corresponding values were 86.04%, 77.14%, 82.2%, 81.8%, and 82.05%. Quantitative apparent diffusion coefficient analysis yielded a sensitivity, specificity, positive predictive value, negative predictive value, and overall diagnostic accuracy of 86.0%, 82.9%, 86.1%, 82.9%, and 84.6%, respectively, using an ADC cut off value of less than 1.15 × 10⁻ 3 mm 2 /s as determined in this study. For the combined O-RADS and ADC assessment, the corresponding values were 90.7%, 85.7%, 88.6%, 88.2%, and 88.5%, respectively. Conclusions Quantitative DWI using ADC values improves the prediction of malignancy in adnexal lesions, enhancing sensitivity and negative predictive value compared with O-RADS MRI alone. ADC assessment is especially valuable when contrast-enhanced imaging is not feasible and may aid surgical planning; however, caution is needed when interpreting ADC in lesions prone to diffusion pitfalls. These findings support the potential for a future O-RADS classification incorporating diffusion metrics to improve risk stratification.
No takes yet. Share an insight, caveat, or question.
Fakhry et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: